Desmoglein-2 and COVID-19 complications: insights into its role as a biomarker, pathogenesis and clinical implications
Description
Desmoglein-2 (DSG2) has emerged as a potential biomarker for coronavirus disease 2019 (COVID-19) complications, particularly cardiac and cardiovascular involvement. The expression of DSG2 in lung tissues has been detected at elevated levels, and
